GlaxoSmithKline plc: company profile and market research reports
GlaxoSmithKline plc is profiled in 50 Custom Market Insights market research reports, spanning healthcare and food & beverages. Our analysts cover the company in the Bile Acid Sequestrants, Topical Antifungals, Direct Oral Anticoagulants, Oophoritis Treatment and Chondrodermatitis Nodularis Helicis markets, among others,. In each study, the GlaxoSmithKline plc profile looks at its business overview, product and service portfolio, financial performance where it is disclosed, and strategic moves such as expansions, acquisitions, partnerships and new product launches. A dedicated GlaxoSmithKline plc company profile brings this together in one document: a global and market level overview, core segments, financials as available, market rank and share, products and services, and recent developments.
Global level overview
- Headquarters
- London, United Kingdom
- Founded
- 2000
- Employees
- 99,300 (2016)
- Ownership
- Public (listed on New York Stock Exchange)
- Website
- gsk.com
What the GlaxoSmithKline plc profile covers
- Company overviewbusiness model, history and geographic footprint
- Key executivesleadership team and decision makers
- Product portfolioproducts and services relevant to each market
- Financial overviewrevenue, segment results and recent performance
- Operating business segmentshow the business is organised and where it earns
- Business performancemarket position, share and growth in the studied markets
- Recent developmentslaunches, partnerships, acquisitions and expansions
Top management of GlaxoSmithKline plc
- Emma WalmsleyChief Executive OfficerSince April 2017
- Jonathan SymondsChairpersonSince September 2019
Recent news about GlaxoSmithKline plc
- Deutsche Bank Remains a Hold on GlaxoSmithKline (GSK)The Globe and Mail · 11 November 2026
Deutsche Bank analyst Emmanuel Papadakis reiterated a Hold rating on GlaxoSmithKline today and set a price target of p2,000.00. According to TipRanks, Papadakis is a 4-star analyst with an average ...
- Buy GlaxoSmithKline Pharmaceuticals; target of Rs 2900: ICICI SecuritiesMoneycontrol · 7 November 2026
ICICI Securities is bullish on GlaxoSmithKline Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2900 in its research report dated November 06, 2026.
Headlines and excerpts from the publishers. Links open their websites.
Reports that profile GlaxoSmithKline plc
- Global Bile Acid Sequestrants Market 2026 – 2035Healthcare · May 2026
- Global Topical Antifungals Market 2026 – 2035Healthcare · May 2026
- Global Direct Oral Anticoagulants Market 2025 – 2034Healthcare · October 2025
- Global Oophoritis Treatment Market 2025 – 2034Healthcare · October 2025
- Global Chondrodermatitis Nodularis Helicis Market 2025 – 2034Healthcare · September 2025
- Global New Oral Anticoagulants Market 2025 – 2034Healthcare · August 2025
- Global Targeted Drug Delivery Market 2025 – 2034Healthcare · August 2025
- Global Paracetamol Market 2025 – 2034Healthcare · July 2025
- Global Pneumothorax Treatment Market 2025 – 2034Healthcare · July 2025
- North America Oral Care Market 2025 – 2034Healthcare · July 2025
- US Pharmaceutical Drug Delivery Market 2025 – 2034Healthcare · May 2025
- Europe Energy Bar Market 2025 – 2034Food & Beverages · March 2025
- Europe Dietary Supplements Market 2024–2033Food & Beverages · September 2024
- US Epilepsy Drugs Market 2024–2033Healthcare · August 2024
- Global Acute Respiratory Infection Market 2024–2033Healthcare · July 2024
- Europe Biotechnology Market 2024–2033Healthcare · July 2024
- US Energy Bar Market 2024–2033Food & Beverages · June 2024
- Global Antifungal Treatment Market 2024–2033Healthcare · May 2024
- Global Anti-Fungal Drugs Market 2024–2033Healthcare · May 2024
- Global Oral Iron Supplements Market 2025 – 2034Healthcare · May 2024
- US Polyclonal Antibody Market 2024–2033Healthcare · May 2024
- Global Non-Small-Cell Lung Cancer Drug Market 2024–2033Healthcare · April 2024
- Global Oral Cancer Treatment Market 2024–2033Healthcare · April 2024
- Global Cancer Supportive Care Drugs Market 2024–2033Healthcare · April 2024
- Global Cancer Pain Market 2024–2033Healthcare · April 2024
- Global Bladder Cancer Market 2024–2033Healthcare · April 2024
- Global Cancer Cachexia Market 2024–2033Healthcare · April 2024
- Global Potassium Clavulanate Market 2024–2033Healthcare · March 2024
- Global Amoxicillin Market 2024–2033Healthcare · March 2024
- Global Cancer Monoclonal Antibodies Market 2024–2033Healthcare · March 2024
- Global Anal Cancer Market 2024–2033Healthcare · March 2024
- Global Lung Tumor Market 2024–2033Healthcare · March 2024
- Global Endometrial Cancer Market 2024–2033Healthcare · March 2024
- Global PARP Inhibitors Market 2024–2033Healthcare · March 2024
- Global Penile Cancer Treatment Market 2024–2033Healthcare · March 2024
- India Pharmaceutical Market 2024–2033Healthcare · March 2024
- Global Pitavastatin Market 2024–2033Healthcare · December 2023
- Global Nifedipine Market 2024–2033Healthcare · December 2023
- Global Antimicrobial Peptides Market 2024–2033Healthcare · December 2023
- Global Bone and Joint Health Supplement Market 2024–2033Healthcare · December 2023
- Global Preventive Vaccine Market 2024–2033Healthcare · December 2023
- Global Organ Transplantation Market 2024–2033Healthcare · November 2023
- Global Acne Treatment Market 2024–2033Healthcare · November 2023
- Global Respiratory Syncytial Virus Vaccine Market 2024–2033Healthcare · October 2023
- Global Gardasil Market 2024–2033Healthcare · September 2023
- Global Chlorpheniramine Maleate Market 2024–2033Healthcare · July 2023
- Global Pharmaceutical Elixir Market 2024–2033Healthcare · June 2023
- Global Antimalarial Drugs Market 2024–2033Healthcare · April 2023
- Global Respiratory Diagnostics Market 2025 – 2034Healthcare · October 2022
- Global Human Insulin Market 2025 – 2034Healthcare · August 2022
What our reports say about GlaxoSmithKline plc
Each report above includes a profile of GlaxoSmithKline plc: business overview, products and services, financials where disclosed and recent developments. Request a free sample to see the profile.
Frequently asked questions
How many Custom Market Insights reports profile GlaxoSmithKline plc?
GlaxoSmithKline plc is profiled in 50 of our market research reports, including the Global Bile Acid Sequestrants Market 2026 – 2035, Global Topical Antifungals Market 2026 – 2035, Global Direct Oral Anticoagulants Market 2025 – 2034.
Which industries do these reports cover?
Healthcare, Food & Beverages.
What does the GlaxoSmithKline plc company profile include?
Global level overview, Market level overview, Core segments, Financials, as available, Strategic information, Market rank and share, Products and services, Recent developments.
How much does the GlaxoSmithKline plc company profile cost?
$140 for the PDF, delivered by email. More companies can be added at checkout: 2nd to 5th profile $90 each, 6th onward $70 each.
Can I see a sample first?
Yes. Request a free sample and an analyst will send it by email, usually within one business day.
